Number of Discovery (WGS) Patients/Sequences by Disease

Sequence~and Analysis~Completed (378): (378, 57.52%) 378
~Public (152): (152, 23.15%) 152
Published (128): (128, 19.48%) 128
378
NBL~(42, 6.39%) 42
ACT~(8, 1.22%) 8
EPD~(22, 3.35%) 22
PHALL~(9, 1.37%) 9
INF~(22, 3.35%) 22
HGG~(15, 2.28%) 15
CBF~(17, 2.59%) 17
OS~(17, 2.59%) 17
128
378
152
LGG (38,5.78%) 38
~RB~(4,0.61%) 4
~MB~(37,5.63%) 37
AMLM7 (4,0.61%) 4
HYPO (20,3.04%) 20
T-ALL (12,1.83%) 12
RHB (13,1.98%) 13
ERG (24, 3.65%) 24
EWS (83, 12.62%) 83
HYPO (2, 0.31%) 2
HYPER (53, 8.06%) 53
LGG (3, 0.46%) 3
ETV (50, 7.6%) 50
INF (4, 0.61%) 4
E2A (33, 5.02%) 33
CPC (4, 0.61%) 4
PHALL (26, 3.96%) 26
MEL (5, 0.76%) 5
RB (11, 1.68%) 11
HGG (20, 3.04%) 20
ACT (12, 1.83%) 12
EPD (17, 2.59%) 17
OS (15, 2.28%) 15
NBL (16, 2.44%) 16
152
128
378
152
128